IPO price
$83.00
Opening trade
$111.50
Recent quote
~$95
November 19, 2026. Recent quote around 3:21 p.m. ET; not a verified closing price.
At $95, someone who bought the opening is already down 14.8%, and someone who bought near the reported $115 high is down 17.4%.
I couldn’t independently confirm your approaching-800-million-share volume figure from the available quotes. But if accurate, that’s extraordinary turnover relative to the 980 million shares offered.
There’s an important distinction: 800 million shares traded does not mean 800 million different investors bought. High-frequency trading and repeated turnover can inflate volume considerably.
Still, the price action tells us something significant:
-
IPO allocation recipients at $83 retain a profit.
-
Public buyers chasing the opening premium are substantially underwater.
-
Heavy turnover accompanied by declining prices suggests supply is overwhelming demand at progressively lower prices.
Reuters is also reporting broad market weakness, including declines in the S&P 500 and Nasdaq, while ANT’s opening enthusiasm evaporates.
Reuters
This is precisely the kind of market action that can transform an IPO liquidity squeeze into a broader confidence problem.
Managers who sold other holdings to buy ANT may now be sitting on immediate losses. If those positions were financed with leverage, the consequences could extend beyond ANT itself.
And the next test is important: does ANT hold above $83 once the opening-day excitement disappears?
If it approaches the offering price on this kind of turnover, the distinction between privileged IPO allocations and public-market buyers starts disappearing. That would be a much more consequential development than today’s fading opening premium.
Leave a Reply